Cargando…

The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience

OBJECTIVES: To determine the effectiveness of Rituximab (RTX) therapy as the first therapeutic choice for the long-term prevention of secondary relapse in children with AIND that had relapse after primary treatment with immunosuppressive agents other than RTX. MATERIALS & METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	NASEHI, Mohammad Mahdi, GHOFRANI, Mohammad, TABRIZI, Aydin, Abdollah GORJI, Fatemeh, KHOSRAVI, Bakhtyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shahid Beheshti University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531201/ https://www.ncbi.nlm.nih.gov/pubmed/36204433 http://dx.doi.org/10.22037/ijcn.v16i3.29322

Ejemplares similares

Epidemiology of Guillain-Barré Syndrome in Iranian Children Aged 0-15 Years (2008-2013)
por: TONEKABONI, Seyed Hassan, et al.
Publicado: (2021)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

Biotinidase Deficiency: A Reversible Neurometabolic Disorder (An Iranian Pediatric Case Series)
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Methylmalonic Acidemia: Diagnosis and Neuroimaging Findings of This Neurometabolic Disorder (An Iranian Pediatric Case Series)
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

The Clinical Features and Diagnosis of Canavan’s Disease: A Case Series of Iranian Patients
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2014)

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
por: Cho, Min-Seok, et al.
Publicado: (2016)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
por: Saffari, Fatemeh, et al.
Publicado: (2022)

Whole Exome Sequencing Reveals a BSCL2 Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient
por: Alaei, Mohammad Reza, et al.
Publicado: (2016)

GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and Neuroimaging Findings (An Iranian Pediatric Case Series)
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2014)

Clinical Trial of Vigabatrin as Adjunctive Therapy in Children with Refractory Epilepsy
por: Taghdiri, Mohammad-Mahdi, et al.
Publicado: (2013)

Performance Comparison of Fuzzy ARTMAP and LDA in Qualitative Classification of Iranian Rosa damascena Essential Oils by an Electronic Nose
por: Gorji-Chakespari, Abbas, et al.
Publicado: (2016)

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
por: Falter, Tanja, et al.
Publicado: (2018)

Clinical and MRI characteristics of multiple sclerosis in Iranian Children and Adolescents
por: NASEHI, Mohammad Mahdi, et al.
Publicado: (2023)

Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series
por: Tzaribachev, Nikolay, et al.
Publicado: (2009)

Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease
por: Papakrivopoulou, Eugenia, et al.
Publicado: (2016)

CNS Genes Implicated in Relapse
por: Kuntz-Melcavage, Kara L, et al.
Publicado: (2008)

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders
por: Yockey, Laura, et al.
Publicado: (2021)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Treg in CNS autoimmune disease
por: Anderton, Stephen M
Publicado: (2012)

Role of Microglia in CNS Autoimmunity
por: Goldmann, Tobias, et al.
Publicado: (2013)

Of primary and secondary CNS autoimmunity
por: Dalmau, Josep
Publicado: (2018)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases
por: Jafarpour, Saba, et al.
Publicado: (2022)

Dietary inflammatory index in relation to severe coronary artery disease in Iranian adults
por: Dadaei, Zahra, et al.
Publicado: (2023)

Cerebrovascular Events in Pediatric Inflammatory Bowel Disease: A Review of Published Cases
por: Rohani, Pejman, et al.
Publicado: (2022)

Comparing Pregabalin and Sodium Valproate in Pediatric Migraine Prophylaxis: A Randomized Clinical Trial
por: JAFARI, Narjes, et al.
Publicado: (2023)

Incidence of Pediatric Multiple Sclerosis in Iran within 2000-2019
por: NASEHI, Mohammad Mahdi, et al.
Publicado: (2022)

HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions
por: TONEKABONI, Seyed Hasan, et al.
Publicado: (2017)

Clinical and Epidemiological Aspects of Multiple Sclerosis in Children
por: NASEHI, Mohammad Mehdi, et al.
Publicado: (2017)

A Successful Treatment of Relapsed Primary CNS Lymphoma Patient with Intraventricular Rituximab Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue
por: Hong, Sung Jin, et al.
Publicado: (2009)

Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- γ release assay and IFN-γ-induced protein-10
por: Ghanaie, Roxana Mansour, et al.
Publicado: (2021)

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma
por: Modelevsky, Lisa, et al.
Publicado: (2018)

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
por: Rezaee, Mehdi, et al.
Publicado: (2022)

Evaluation of One Hundred Pediatric Muscle Biopsies During A 2-Year Period in Mofid Children And Toos Hospitals
por: NILIPOR, Yalda, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iado30l4idn344fm0b3s8lfi4v